[Drug-induced hepatits: the role of unstable metabolites (author's transl)].
D000818:Animals; D001711:Biotransformation; D056486:Chemical and Drug Induced Liver Injury / Q000378:metabolism*; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D005978:Glutathione / Q000378:metabolism; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D012293:Rifampin / Q000009:adverse effects / Q000378:metabolism
D004364:Pharmaceutical Preparations; D003577:Cytochrome P-450 Enzyme System; D005978:Glutathione; D007538:Isoniazid; D012293:Rifampin
Hépatites médicamenteuses dues à des métabolites instables.